165 related articles for article (PubMed ID: 9671748)
41. High resolution mapping of UV-induced photoproducts in the Escherichia coli lacI gene. Inefficient repair of the non-transcribed strand correlates with high mutation frequency.
Chandrasekhar D; Van Houten B
J Mol Biol; 1994 May; 238(3):319-32. PubMed ID: 8176728
[TBL] [Abstract][Full Text] [Related]
42. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
43. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.
Lin DP; Wang Y; Scherer SJ; Clark AB; Yang K; Avdievich E; Jin B; Werling U; Parris T; Kurihara N; Umar A; Kucherlapati R; Lipkin M; Kunkel TA; Edelmann W
Cancer Res; 2004 Jan; 64(2):517-22. PubMed ID: 14744764
[TBL] [Abstract][Full Text] [Related]
44. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
[TBL] [Abstract][Full Text] [Related]
45. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.
Zhu YM; Das-Gupta EP; Russell NH
Blood; 1999 Jul; 94(2):733-40. PubMed ID: 10397740
[TBL] [Abstract][Full Text] [Related]
46. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.
Haraldsdottir S; Hampel H; Tomsic J; Frankel WL; Pearlman R; de la Chapelle A; Pritchard CC
Gastroenterology; 2014 Dec; 147(6):1308-1316.e1. PubMed ID: 25194673
[TBL] [Abstract][Full Text] [Related]
47. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
[TBL] [Abstract][Full Text] [Related]
48. Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations.
Abuin A; Zhang H; Bradley A
Mol Cell Biol; 2000 Jan; 20(1):149-57. PubMed ID: 10594017
[TBL] [Abstract][Full Text] [Related]
49. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
50. The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch.
Lamers MH; Perrakis A; Enzlin JH; Winterwerp HH; de Wind N; Sixma TK
Nature; 2000 Oct; 407(6805):711-7. PubMed ID: 11048711
[TBL] [Abstract][Full Text] [Related]
51. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
52. A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency.
Ji HP; King MC
Hum Mol Genet; 2001 Nov; 10(24):2737-43. PubMed ID: 11734538
[TBL] [Abstract][Full Text] [Related]
53. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
54. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
Qin X; Liu L; Gerson SL
Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
[TBL] [Abstract][Full Text] [Related]
55. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
56. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
[TBL] [Abstract][Full Text] [Related]
57. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
58. Mutation frequency in the lacI gene of liver DNA from lambda/lacI transgenic mice following the interaction of PCBs with iron causing hepatic cancer and porphyria.
Davies R; Clothier B; Smith AG
Mutagenesis; 2000 Sep; 15(5):379-83. PubMed ID: 10970442
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous mutation in the Escherichia coli lacI gene.
Schaaper RM; Dunn RL
Genetics; 1991 Oct; 129(2):317-26. PubMed ID: 1660424
[TBL] [Abstract][Full Text] [Related]
60. Mouse models for human DNA mismatch-repair gene defects.
Wei K; Kucherlapati R; Edelmann W
Trends Mol Med; 2002 Jul; 8(7):346-53. PubMed ID: 12114115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
